Replacement of the superior vena cava by the bovine pericardium conduit: Sustained patency without long-term anticoagulation
The Journal of Thoracic and Cardiovascular Surgery · 2026
DOI: 10.1016/j.jtcvs.2025.07.008 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Thoracic and Cardiovascular Surgery, 2026. Verfasst von Giacomo Argento und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Thoracic Surgery, Sant'Andrea Hospital, La Sapienza University of Rome, Rome, Italy. Electronic address: giacomo.argento@uniroma1.it. Hauptthemen laut MEDLINE: Vena Cava, Superior, Pericardium, Vascular Patency, Lung Neoplasms. Die Arbeit nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
OBJECTIVES: Direct infiltration of the superior vena cava by thoracic malignancies often requires en bloc resection and vascular reconstruction. Synthetic grafts such as polytetrafluoroethylene are associated with thrombosis and long-term anticoagulation. We present a large experience with bovine pericardium conduits for superior vena cava replacement, focusing on durable patency without long-term anticoagulation. METHODS: Between 2003 and 2024, 61 patients with superior vena cava infiltration underwent replacement with a bovine pericardium conduit. Indications included lung cancer (40 cases) and thymic tumors (21 cases). Vascular reconstruction was performed using crossclamping without shunt. Postoperative follow-up included regular imaging studies (computed tomography and magnetic resonance imaging) to assess conduit patency and clinical outcomes. RESULTS: All patients achieved complete R0 resection. No long-term anticoagulation therapy was required postoperatively. Follow-up imaging confirmed long-term conduit patency in all surviving patients over 1 to 5 years, except 1 patient with jugular vein thrombosis secondary to a port-a-cath. The 30-day mortality rate was 6.5% (4 patients), with no deaths due to vascular complications. Major complications occurred in 9.8% of cases. For thymic tumors, the 5-year survival was 53.7%, whereas for lung cancer, it was 38.8%. CONCLUSIONS: Bovine pericardium conduits offer a safe and effective option for superior vena cava replacement, providing excellent prolonged patency without long-term anticoagulation. This biological material reduces the risks associated with synthetic grafts, representing a valuable alternative in complex vascular reconstructions. Broader adoption could significantly improve outcomes for patients undergoing superior vena cava replacement.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Thoracic Surgery, Sant'Andrea Hospital, La Sapienza University of Rome, Rome, Italy. Electronic address: giacomo.argento@uniroma1.it.
- Division of Thoracic Surgery, Sant'Andrea Hospital, La Sapienza University of Rome, Rome, Italy.
- Division of Thoracic Surgery, Policlinico Umberto I, La Sapienza University of Rome, Rome, Italy.
Zitieren
APA
Argento, G., Rendina, E. A., D'Andrilli, A., Ciccone, A. M., Ibrahim, M., Trabalza Marinucci, B., Venuta, F., & Maurizi, G. (2026). Replacement of the superior vena cava by the bovine pericardium conduit: Sustained patency without long-term anticoagulation. The Journal of Thoracic and Cardiovascular Surgery. https://doi.org/10.1016/j.jtcvs.2025.07.008
Vancouver
Argento G, Rendina EA, D'Andrilli A, Ciccone AM, Ibrahim M, Trabalza Marinucci B, et al. Replacement of the superior vena cava by the bovine pericardium conduit: Sustained patency without long-term anticoagulation. The Journal of Thoracic and Cardiovascular Surgery. 2026. doi:10.1016/j.jtcvs.2025.07.008
BibTeX
@article{Argento2026,
author = {Argento, Giacomo and Rendina, Erino Angelo and D'Andrilli, Antonio and Ciccone, Anna Maria and Ibrahim, Mohsen and Trabalza Marinucci, Beatrice and Venuta, Federico and Maurizi, Giulio},
title = {Replacement of the superior vena cava by the bovine pericardium conduit: Sustained patency without long-term anticoagulation},
journal = {The Journal of Thoracic and Cardiovascular Surgery},
year = {2026},
doi = {10.1016/j.jtcvs.2025.07.008}
}
EUVIMED